Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F
about
Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titersStructure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing EpitopesDefining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigenStructure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing AntibodyStructure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial VirusAnalysis of Human RSV Immunity at the Molecular Level: Learning from the Past and PresentProtein Crystallography in Vaccine Research and DevelopmentMax Bergmann lecture protein epitope mimetics in the age of structural vaccinologyCharacterization of neutralizing affinity-matured human respiratory syncytial virus F binding antibodies in the sub-picomolar affinity range.Structure and function of respiratory syncytial virus surface glycoproteins.A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanismMolecular characterization of circulating respiratory syncytial virus (RSV) genotypes in Gilgit Baltistan Province of Pakistan during 2011-2012 winter seasonA broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus.Structure and immune recognition of trimeric pre-fusion HIV-1 Env.A study of the genetic variability of human respiratory syncytial virus (HRSV) in Cambodia reveals the existence of a new HRSV group B genotype.Characterization of hospital and community-acquired respiratory syncytial virus in children with severe lower respiratory tract infections in Ho Chi Minh City, Vietnam, 2010.Progress in understanding and controlling respiratory syncytial virus: still crazy after all these yearsCharacterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion GlycoproteinCholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cellsMultiple B-cell epitope vaccine induces a Staphylococcus enterotoxin B-specific IgG1 protective response against MRSA infectionMechanism for pre-B cell loss in VH-mutant rabbitsIBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.Novel antigens for RSV vaccines.A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSVEngineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation.Vaccines against respiratory syncytial virus: The time has finally come.Sendai virus as a backbone for vaccines against RSV and other human paramyxovirusesRapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donorsNeutralizing epitopes on the respiratory syncytial virus fusion glycoprotein.Respiratory Syncytial Virus: The Influence of Serotype and Genotype Variability on Clinical Course of Infection.Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection.Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus.Cimicifuga foetida L. inhibited human respiratory syncytial virus in HEp-2 and A549 cell lines.Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats.Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion Protein.Functional correlations of respiratory syncytial virus proteins to intrinsic disorder.Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells.Scop3D: three-dimensional visualization of sequence conservation.Cross-neutralization of four paramyxoviruses by a human monoclonal antibody.A study of the genetic variability of human respiratory syncytial virus in Croatia, 2006-2008.
P2860
Q27667876-A0B38EDE-AAC0-447B-800C-8706D492F456Q27668015-9B0EDE9A-D4DF-4902-B2E8-FC7FFA8D4B51Q27676318-18310A6E-5001-447B-BD38-66602313760EQ27677570-00B888FB-7DAE-4B0F-A7E8-1ED1DBF0C2AAQ27680499-58D39FA6-3819-4B20-B154-9C11C48652DEQ28080556-AB9B69DE-FBF2-4FEE-9A3B-9059081E289DQ28087528-46DCD8A6-F1C6-4DA8-AED8-5C81E3CEE759Q30155145-30F73B70-599A-483B-BAB2-5A7AD83F8F38Q34191108-362129BC-351C-40A3-9251-8968491851E1Q34414405-FB658052-8EE1-4307-96CA-5398C90088A2Q34492100-D4D96D2B-351B-4140-A583-EE2A6787A592Q34994494-56AD18F7-2D75-4EFA-946D-A8F34E6B4A7AQ35127300-3B555C49-D0CB-4BCF-AF35-5B177A1539E7Q35142291-7B602521-E8AD-431A-9E85-5B488DD03C3EQ35273655-3B778EF0-A94B-46F2-B40F-C1D450020553Q35557357-F7A5FD5B-7523-4BA7-98D1-3D004D417947Q35566601-C6A3D08F-6017-4537-9DC2-5E60BCA4EA9DQ35687662-A3A6A7E3-CE84-47DD-AA20-29365BFACF89Q35689697-A1EA4BCC-E9C6-4C2F-AC77-975144F758AAQ35880774-4C994D02-955A-4E9A-BFA3-7C5C8138B195Q35920333-DACA4F54-E69B-40C3-B3C1-A2B562F2ED75Q35992493-A0FC8AFD-0EA0-4B45-9038-597BD099C72AQ36005960-A96F76D5-F1F4-4E42-83A3-E32CD740B70EQ36029158-F5AB509E-927F-4A68-819E-3FAFA7258504Q36128048-E48FD522-1B34-4C71-9C7C-5EF2F0DF925CQ37018347-A756CB86-B8CC-465D-B691-2DBB1F2753F0Q37118707-2531F86A-5C3F-4F33-BFBC-9251B88CEA47Q37593886-14345C0F-BB65-415D-AC6A-2D131EF6B018Q38394731-F7D9C89A-2D83-4A5B-83BE-914A406B2F61Q38637248-FD9BC169-B833-4C52-B32F-5D36E378BBBCQ38750689-9FB132C1-D87E-493A-BBCB-ED41825DD7FAQ39289483-E372F230-28EC-48D2-868B-2263C2938C72Q39402884-7866CBF0-A326-4A97-91CF-FEFF293FECA2Q39868227-E106763A-E4A0-4090-9543-FDE9F49E1131Q40216566-31755FE4-6019-41BD-AA76-7EEA58ADAC11Q40721101-51C6642C-988F-496A-9D48-34F9FA9C1632Q40959795-1FEF3E4D-A099-4763-A8F6-13059B707C8CQ42173061-AE2EA9C7-716E-47AD-9E34-B9F508B0EE9CQ42275949-64524BAA-83A7-4214-9D2E-EB4FCD82CC2EQ44288287-B6BD9A44-F20C-4162-B301-8A21ADEFA722
P2860
Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Structure of a Major Antigenic ...... ith Neutralizing Antibody 101F
@ast
Structure of a Major Antigenic ...... ith Neutralizing Antibody 101F
@en
Structure of a Major Antigenic ...... ith Neutralizing Antibody 101F
@nl
type
label
Structure of a Major Antigenic ...... ith Neutralizing Antibody 101F
@ast
Structure of a Major Antigenic ...... ith Neutralizing Antibody 101F
@en
Structure of a Major Antigenic ...... ith Neutralizing Antibody 101F
@nl
prefLabel
Structure of a Major Antigenic ...... ith Neutralizing Antibody 101F
@ast
Structure of a Major Antigenic ...... ith Neutralizing Antibody 101F
@en
Structure of a Major Antigenic ...... ith Neutralizing Antibody 101F
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Structure of a major antigenic ...... ith neutralizing antibody 101F
@en
P2093
Jung-San Chang
Peter D Kwong
Yongping Yang
P2860
P304
12236-12244
P3181
P356
10.1128/JVI.01579-10
P577
2010-09-29T00:00:00Z